Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To study the effects of dose and duration of the HCV polymerase inhibitor prodrug (RO5024048) in combination with PEG-IFN and RBV versus the currently approved combination of PEG-IFN and RBV (SOC) in treatment-naive patients with chronic hepatitis C genotype 1 and 4 virus infection.
Critère d'inclusion
- Chronic hepatitis C